← Back to headlines
Outlook Therapeutics (OTLK) Receives July 29 PDUFA Date for LYTENAVA
Outlook Therapeutics (OTLK) has been assigned a PDUFA date of July 29 for its drug candidate LYTENAVA, a key regulatory milestone.
14 Jul, 18:08 — 14 Jul, 18:08
Sources
Showing 1 of 1 sources
